100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 100010 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 100020 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 100030 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 100040 - Statement - Consolidated Statements of Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 100050 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 100060 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 100070 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Nature of Business link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Collaborative Research and License Agreements link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - (Loss) Earnings per Share link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Significant Agreements link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Property and Equipment, net link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Prepaid Expenses and Other Current Assets link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Accrued Expenses and Other Current Liabilities link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - Common Stock link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Loan Payable link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - Supplemental Cash Flow Information link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - (Loss) Earnings per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Property and Equipment, net (Tables) link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Common Stock (Tables) link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - Loan Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 995725 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 995735 - Disclosure - Supplemental Cash Flow Information (Tables) link:presentationLink link:calculationLink link:definitionLink 995745 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995755 - Disclosure - Collaborative Research and License Agreements - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995765 - Disclosure - Leases - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995775 - Disclosure - Leases - Summary of Future Minimum Lease Payments under Operating Leases (Detail) link:presentationLink link:calculationLink link:definitionLink 995785 - Disclosure - (Loss) Earnings per Share - Computation of Basic and Diluted Earnings (Loss) per Share (Detail) link:presentationLink link:calculationLink link:definitionLink 995795 - Disclosure - (Loss) Earnings per Share - Potential Dilutive Securities Excluded from Computation of Diluted Net Loss per Common Share (Detail) link:presentationLink link:calculationLink link:definitionLink 995805 - Disclosure - (Loss) Earnings per Share - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995815 - Disclosure - Significant Agreements - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995825 - Disclosure - Property and Equipment, Net - Property and Equipment, Net (Detail) link:presentationLink link:calculationLink link:definitionLink 995835 - Disclosure - Property and Equipment, Net - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995845 - Disclosure - Fair Value Measurements - Schedule of Fair Values of Financial Assets and Liabilities Measured at Fair Value (Detail) link:presentationLink link:calculationLink link:definitionLink 995855 - Disclosure - Fair Value Measurements - Significant Unobservable Inputs in the Fair Value Measurement (Detail) link:presentationLink link:calculationLink link:definitionLink 995865 - Disclosure - Fair Value Measurements - Summary of Fair Value (Detail) link:presentationLink link:calculationLink link:definitionLink 995875 - Disclosure - Fair Value Measurements - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995885 - Disclosure - Fair Value Measurements - Summary of Available-for-Sale Securities (Detail) link:presentationLink link:calculationLink link:definitionLink 995895 - Disclosure - Prepaid Expenses and Other Current Assets - Schedule of Prepaid Expenses and Other Current Assets (Detail) link:presentationLink link:calculationLink link:definitionLink 995905 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Detail) link:presentationLink link:calculationLink link:definitionLink 995915 - Disclosure - Common Stock - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995925 - Disclosure - Common Stock - Schedule of Common Stock Reserved for Future Issuance (Detail) link:presentationLink link:calculationLink link:definitionLink 995935 - Disclosure - Stock-Based Compensation - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995945 - Disclosure - Stock-Based Compensation - Share Based Compensation Expense Related to Issuance of Stock Option Awards to Employees and Non Employees Related to Employee Stock Purchase Plan (Detail) link:presentationLink link:calculationLink link:definitionLink 995955 - Disclosure - Stock-Based Compensation - Grant Date Fair Values of Options Issued to Employees and Non-employees Estimated Using Black-Scholes Option Pricing Model (Detail) link:presentationLink link:calculationLink link:definitionLink 995965 - Disclosure - Stock-Based Compensation - Summary of Company's Stock Option Activity (Detail) link:presentationLink link:calculationLink link:definitionLink 995975 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Units Activity (Detail) link:presentationLink link:calculationLink link:definitionLink 995985 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Units Activity (Parenthetical) (Details) link:presentationLink link:calculationLink link:definitionLink 995995 - Disclosure - Loan Payable - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 996005 - Disclosure - Loan Payable - Summary of Maturities of Principal Obligations Under Long-term Debt (Detail) link:presentationLink link:calculationLink link:definitionLink 996015 - Disclosure - Income Taxes - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 996025 - Disclosure - Income Taxes - Schedule of Reconciliation of Provision for Income Taxes Computed at Statutory Federal Income Tax Rate to Provision for Income Taxes (Detail) link:presentationLink link:calculationLink link:definitionLink 996035 - Disclosure - Income Taxes - Components of Deferred Tax (Detail) link:presentationLink link:calculationLink link:definitionLink 996045 - Disclosure - Income Taxes - Summary of Reconciliation of Company's Unrecognized Tax Benefits (Detail) link:presentationLink link:calculationLink link:definitionLink 996055 - Disclosure - Commitments and Contingencies - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 996065 - Disclosure - Supplemental Cash Flow Information - Supplemental Disclosures of Cash Flow (Detail) link:presentationLink link:calculationLink link:definitionLink Auditor Firm ID Auditor Firm ID 2024 Lessee, Operating Lease, Liability, to be Paid, Year One Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative Document Transition Report Document Transition Report Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Volatility rate Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Options outstanding, Weighted Average Remaining Contractual Term Deferred Tax Assets, in Process Research and Development Research and development credits Revenue, Remaining Performance Obligation, Amount Upfront payment allocation to performance obligation Clinical trial. Clinical Trial [Member] Clinical Trial [Member] Class of warrant or right issued. Class Of Warrant Or Right Issued Warrant issued Geographical [Axis] Geographical Share based compensation arrangement by share based payment award annual increase percentage in number of shares available for grant. Share Based Compensation Arrangement By Share Based Payment Award Annual Increase Percentage In Number Of Shares Available For Grant Common stock outstanding Series two warrants. Series Two Warrants [Member] Series 2 Warrants [Member] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Summary of Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Vesting period Debt Securities, Available-for-Sale Fair Value Debt Securities, Available-for-Sale, Total Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other assets Restricted Stock Units (RSUs) [Member] Non-Vested Restricted Stock Units (RSUs) [Member] Restricted Stock Units (RSUs) [Member] Fair Value, Inputs, Level 1 [Member] Quoted Prices in Active Markets Level 1 [Member] Entity Public Float Entity Public Float Weighted Average [Member] Weighted Average [Member] Finance Lease, Liability, to be Paid Future minimum lease payments under capital leases Finance Lease, Liability, to be Paid, Total Income Tax, Policy [Policy Text Block] Income Taxes Property, Plant and Equipment, Useful Life Estimated useful lives Revenue from Contract with Customer, Excluding Assessed Tax Total revenues Total revenues Additional default interest rate. Additional Default Interest Rate Default interest rate Number of common stock warrants issued. Number Of Common Stock Warrants Issued Number of common stock warrants issued Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Increase (decrease) in valuation allowance ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Loss Contingency, Pending Claims, Number Indemnification obligations, claims outstanding Non refundable up front payment received. Non Refundable Up Front Payment Received Up-front license fee received Lessee Operating Lease Liability Payments Due After Year Two Lessee Operating Lease Liability Payments Due After Year Two Thereafter Offering price per share. Offering Price Per Share Offering price Title of Individual [Domain] Title of Individual Upfront payments to be returned upon termination of agreement. Upfront Payments To Be Returned Upon Termination Of Agreement Upfront payments returned upon termination of agreement Name of Property [Domain] Research and Development [Abstract] UCB license agreement. Ucb License Agreement [Member] UCB License Agreement [Member] Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of Fair Values of Financial Assets and Liabilities Measured at Fair Value Line of credit facility elected not to draw. Line Of Credit Facility Elected Not To Draw Line of credit facility elected not to draw Operating Lease, Liability, Noncurrent Right-of-use liability, less current portion Schedule of Stock by Class [Table] Schedule Of Stock By Class [Table] Fair Value Measurement [Domain] Fair Value Measurement Debt Securities, Available-for-Sale [Table] Debt Securities Available For Sale [Table] Liabilities, Fair Value Disclosure Total Liabilities Class of Stock [Line Items] Class Of Stock [Line Items] Assets, Current Total current assets Prepayment Fee Prepayment Fee Payments for Other Fees Liabilities and Equity Total liabilities and stockholders' equity Entity Address, State or Province Entity Address, State or Province Deferred Tax Assets, Other Other temporary differences Stock Issued During Period, Value, New Issues Common stock issued at fair value Proceeds from Incyte Share Purchase Agreement Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Options outstanding, Ending balance Options outstanding, Beginning balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted-average grant date fair value of options granted Comprehensive (loss) income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Trading Symbol Trading Symbol Deferred Tax Assets, Net of Valuation Allowance Net deferred tax assets Costs related to cost sharing collaborations. Costs Related To Cost Sharing Collaborations External costs related to cost-sharing collaborations Debt Securities, Available-for-Sale [Line Items] Schedule Of Available For Sale Securities [Line Items] Long-Term Debt, Maturity, Year Two 2023 Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Fair value of restricted stock units vested Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Total prepaid expenses and other current assets Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Net Income (Loss) Attributable to Parent [Abstract] Numerator: Office and computer equipment. Computer And Office Equipment [Member] Office and Computer Equipment [Member] Remaining contractual obligation. Remaining Contractual Obligation Remaining contractual obligation Commitment And Contingencies [Table] Commitment And Contingencies [Table] Commitment And Contingencies [Table] Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Table] Shares, Outstanding Ending balance, Shares Beginning balance, Shares Lessee, Operating Lease, Liability, to be Paid, Year Three 2025 Common Stock, Capital Shares Reserved for Future Issuance Shares available for issuance Percentage of prepayment premium of principal amount outstanding thereafter. Percentage Of Prepayment Premium Of Principal Amount Outstanding Thereafter Percentage of prepayment premium of principal amount outstanding thereafter prior to maturity date AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Income (Loss) [Member] 2022 Performance Awards [Member] Two Thousand And Twenty Two Performance Awards [Member] Two thousand and twenty two performance awards. NEW YORK New York [Member] Upfront payments received. Upfront Payments Received License agreement upfront payment received Entity Address, City or Town Entity Address, City or Town Stock issued during period value pre-funded common stock warrants from direct offering. Stock Issued During Period Value Pre Funded Common Stock Warrants From Direct Offering Proceeds from pre-funded common stock warrant from direct offering, net, value Operating Lease, Weighted Average Discount Rate, Percent Operating lease discount rate Class of Warrant or Right, Outstanding Warrants outstanding Line of credit facility minimum cash covenant waived. Line Of Credit Facility Minimum Cash Covenant Waived Minimum cash covenant waived Cash Flow, Supplemental Disclosures [Text Block] Supplemental Cash Flow Information Debt Disclosure [Text Block] Loan Payable Property, Plant and Equipment [Table Text Block] Property and Equipment, Net Subsequent Event [Member] Subsequent Event [Member] Subsequent Event Type [Axis] Subsequent Event Type Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Options canceled, forfeited or expired, Weighted Average Exercise Price Additional Paid-in Capital [Member] Additional Paid-In Capital [Member] Non-US [Member] Ex-U.S. Countries [Member] Employee service share based compensation recognized stock options not met. Employee Service Share Based Compensation Recognized Stock Options Not Met Recognized compensation expense related to stock option not met Valuation Allowance, Methodologies and Assumptions Valuation allowance for deferred tax assets, description Indemnification Agreement [Member] Guarantees and Indemnifications [Member] Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction Issuance costs included in accounts payable and accrued expenses Liabilities, Current [Abstract] Current liabilities: service based options. Service Based Options [Member] Service Based Options [Member] Assets, Current [Abstract] Current assets: Counterparty Name [Axis] Counterparty Name Accrued milestone expenses. Accrued Milestone Expenses Accrued milestone expenses Preferred Stock, Par or Stated Value Per Share Preferred stock, par value Statement of Stockholders' Equity [Abstract] Stock issued during period value direct offering. Stock Issued During Period Shares Direct Offering Proceeds from direct offering,net, Shares Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false] Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false] Two thousand and seventeen performance awards. Two Thousand And Seventeen Performance Awards [Member] 2017 Performance Awards [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Options vested, exercisable or expected to vest, Weighted Average Exercise Price, Ending balance Operating Lease, Liability, Current Current portion of right-of-use liability Marketable Securities, Policy [Policy Text Block] Marketable Securities Lender Name [Axis] Lender Name Line of Credit Facility, Frequency of Payment and Payment Terms Interest-only period, terms Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Grant Date Fair Values of Options Issued to Employees and Non-employees Estimated Using Black-Scholes Option Pricing Model Debt Instrument, Maturity Date Maturity date Fair value of warrants. Fair Value Of Warrants Total fair value of warrant Property, Plant and Equipment, Net Property and equipment, net Property and equipment, net Current portion of capital lease. Current Portion Of Capital Lease Investment Income, Interest Interest income Return to provision true up Return to provision true up Return to provision true up Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Options vested, exercisable or expected to vest, Aggregate Intrinsic Value Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Income tax computed at federal statutory rate Warrant, cashless exercise shares Warrant Cashless Exercise Shares Warrant Cashless Exercise Shares Business Combination, Contingent Consideration, Liability Contingent liabilities Business Combination, Contingent Consideration, Liability, Total Statement of Comprehensive Income [Abstract] Scenario [Domain] Scenario Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative Entity Central Index Key Entity Central Index Key Class of Warrant or Right, Number of Securities Called by Warrants or Rights Warrants issued (in shares) Plan Name [Domain] Plan Name Change in Accounting Principle, Accounting Standards Update, Adopted [true false] Change in Accounting Principle, Accounting Standards Update, Adopted [true false] Two thousand seven and two thousand fifteen stock incentive plan. Two Thousand Seven And Two Thousand Fifteen Stock Incentive Plan [Member] 2007 and 2015 [Member] US Treasury and Government [Member] US Treasury and Federal Bonds [Member] Restricted Cash, Noncurrent Restricted cash Restricted cash Assets, Fair Value Disclosure Total assets Lessee, Operating Lease, Option to Extend Lessee, Operating Lease, Option to Extend Adjustments to additional paid in capital repricing warrants. Adjustments To Additional Paid In Capital Repricing Warrants Deemed dividend transferred to the warrant holders Repricing Series 1 and 2 warrants Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Preferred Stock, Shares Outstanding, Beginning Balance Preferred Stock, Shares Outstanding, Ending Balance Amortized losses reacquired debt noncurrent. Amortized Losses Reacquired Debt Noncurrent Amortized final fee Liabilities, Current Total current liabilities Entity Tax Identification Number Entity Tax Identification Number Maximum period allowed to increase beneficial ownership limitation after notice. Maximum Period Allowed To Increase Beneficial Ownership Limitation After Notice Maximum period allowed to increase beneficial ownership limitation after notice Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Equity based compensation Stock Issued During Period, Value, Employee Stock Purchase Plan Stock purchase under ESPP Lessee, Operating Leases [Text Block] Leases Guarantees, Indemnifications and Warranties Policies [Policy Text Block] Guarantees and Indemnifications Warrant expiration term. Warrant Expiration Term Warrant expiration period Share-Based Payment Arrangement, Disclosure [Abstract] Plan Name [Axis] Plan Name Geographical [Domain] Geographical Assets Total assets Series B-1 purchase agreement. Series B1 Purchase Agreement [Member] Eddingpharm Purchase Agreement [Member] Operating Lease, Right-of-Use Asset Right-of-use asset, net Right-of-use asset Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Unrecognized compensation expense related to stock option Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Accrued expenses and other liabilities Entity Registrant Name Entity Registrant Name Debt instrument tranche two Debt Instrument Tranche Two [Member] Tranche 2 [Member] Components of Deferred Tax Assets [Abstract] Entity Address, Address Line Three Entity Address, Address Line Three Lessee, Operating Lease, Existence of Option to Extend [true false] Lease option to extend Lessee, Lease, Description [Line Items] Lessee Lease Description [Line Items] Retained Earnings (Accumulated Deficit) Accumulated deficit Retained Earnings (Accumulated Deficit), Total Proceeds from Stock Plans Proceeds from ESPP Supplemental Cash Flow Information [Abstract] Capital lease, less current portion. Capital Lease Less Current Portion Retained Earnings [Member] Accumulated Deficit [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Number of Shares, Unvested, Ending balance Number of Shares, Unvested, Beginning balance Stock Issued During Period, Shares, Employee Stock Purchase Plans Stock purchase under ESPP, Shares Number of shares issued under plan Minimum [Member] Minimum [Member] Proceeds from Stock Options Exercised Stock options exercised Proceeds from stock option exercises Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Schedule of Prepaid Expenses and Other Current Assets Operating Lease, Liability Operating Lease, Liability, Total Total operating lease liability Operating lease liabilities Hercules Capital, Inc. Hercules Capital Inc [Member] Hercules [Member] Forecast [Member] Scenario Forecast [Member] Equity Component [Domain] Equity Component Change in Accounting Principle, Accounting Standards Update, Adoption Date Change in Accounting Principle, Accounting Standards Update, Adoption Date Derivative Liability, Current Derivative liability Employee service share based compensation recognized stock options. Employee Service Share Based Compensation Recognized Stock Options Stock compensation expense Upfront payments allocated to equity purchase fair value. Upfront Payments Allocated To Equity Purchase Fair Value Up-front payment allocated to preferred stock value Estimated standalone selling price of license agreement. Estimated Standalone Selling Price Of License Agreement Estimated standalone selling price of license agreement At-the-market program [Member] At-the-market program [Member] At-the-market program [Member] Debt instrument interest only period expiration date. Debt Instrument Interest Only Period Expiration Date Interest-only period expiration date Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract] Adjustments to reconcile net loss to net cash provided (used in) operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Debt Disclosure [Abstract] Debt Instrument, Basis Spread on Variable Rate Basis spread on variable rate Entity Current Reporting Status Entity Current Reporting Status Common Stock, Shares Authorized Common stock, shares authorized Research and Development Expense Research and development Research and development expense Research and Development Expense, Total Debt, Policy [Policy Text Block] Debt Issuance Cost Revenue recognized upon transfer of license agreement. Revenue Recognized Upon Transfer Of License Agreement Revenue recognized upon transfer of license agreement Assets [Abstract] ASSETS Proceeds from Issuance of Common Stock Aggregate purchase price Proceeds from issuance of common stock in follow-on public stock offering, net Revenue from Contract with Customer [Policy Text Block] Revenue Recognition Incyte corporation. Incyte Corporation [Member] Incyte Corporation [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Common stock reserved for issuance Measurement Input, Expected Term [Member] Measurement Input, Expected Term [Member] Interest Receivable, Current Interest receivable on investments Common stock, $0.0001 par value, 200,000,000 and 100,000,000 shares authorized at December 31, 2023 and December 31, 2022, respectively; 84,826,632 and 68,111,385 shares outstanding at December 31, 2023 and December 31, 2022, respectively Common Stock, Value, Issued Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Change in valuation allowance Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Accrued Expenses and Other Current Liabilities Other Noncash Income (Expense) Other Other Noncash Income (Expense), Total Registration Payment Arrangement by Arrangement [Axis] Registration Payment Arrangement by Arrangement Loans Payable Total Upfront payments. Upfront Payments Upfront milestone payable Contract with Customer, Liability, Revenue Recognized Milestone payment received Furniture and Fixtures [Member] Furniture and Fixtures [Member] Exercise of warrants upper limit after exercise as percentage of common stock. Exercise Of Warrants Upper Limit After Exercise As Percentage Of Common Stock Maximum percentage of common stock can be held upon exercise of warrant Current Fiscal Year End Date Current Fiscal Year End Date Share-Based Payment Arrangement, Noncash Expense Stock-based compensation Share-Based Payment Arrangement, Noncash Expense, Total Auditor Name Auditor Name Unrecognized Tax Benefits, Period Increase (Decrease) Uncertain tax positions Unrecognized Tax Benefits, Period Increase (Decrease), Total Operating Income (Loss) (Loss) income from operations Accounting Standards Update 2019-12 [Member] ASU No. 2019-12 [Member] Debt Securities, Available-for-Sale, Realized Gain (Loss) Realized gains or losses recognized on the sale or maturity of available-for-sale securities Debt Securities, Available-for-Sale, Realized Gain (Loss), Total Entity Ex Transition Period Tax Period [Axis] Tax Period Derivative liability expected timing of the termination right. Derivative Liability Expected Timing Of Termination Right Expected timing of the Termination Right Income Tax Expense (Benefit) Net tax provision Income Tax Expense (Benefit), Total Research and Development Expense [Member] Research and Development [Member] Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Decreases related to prior period positions Nature of Operations [Text Block] Nature of Business Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale Proceeds from sales and maturities of short-term investments Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale, Total Stock issued during period value at the market offering net. Stock Issued During Period Value At The Market Offering Net Proceeds from "at-the-market" offering, net, Value Share-based compensation arrangement by share-based payment award payroll deductions offering period. Share Based Compensation Arrangement By Share Based Payment Award Payroll Deductions Offering Period Periodic payroll deductions offering periods Significant agreements disclosure. Significant Agreements Disclosure [Text Block] Significant Agreements Share-Based Payment Arrangement, Expense Stock compensation expense Share based compensation expense, total Measurement Input Type [Domain] Measurement Input Type Equipment [Member] Equipment [Member] Maximum beneficial ownership limitation percentage. Maximum Beneficial Ownership Limitation Percentage Maximum beneficial ownership limitation percentage Accumulated other comprehensive income (loss) AOCI, Debt Securities, Available-for-Sale, Adjustment, after Tax Valuation Approach and Technique [Domain] Valuation Approach and Technique Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures Stock option granted to certain employees Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures, Total Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Impairment of Long-Lived Assets Other Comprehensive Income (Loss), Net of Tax [Abstract] Other comprehensive gain (loss): Stock Issued During Period, Shares, Restricted Stock Award, Gross Vesting of RSU, Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Options outstanding, Aggregate Intrinsic Value Employees. Employees [Member] Employees [Member] Federal Bonds [Member] Federal Bonds [Member] Federal bonds. (Loss) Earnings Per Share Earnings Per Share, Policy [Policy Text Block] Depreciation and related adjustment. Depreciation And Related Adjustment Depreciation Measurement Basis [Axis] Measurement Basis Effective Income Tax Rate Reconciliation, Tax Credit, Percent General business credit carryovers Effective Income Tax Rate Reconciliation, Tax Credit, Percent, Total Other (expense) income, net Other Nonoperating Income (Expense) Other Nonoperating Income (Expense), Total Stock issued during period value offering expenses. Stock Issued During Period Value Offering Expenses Direct offering, offering expenses Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Payments for (Proceeds from) Deposit on Loan Payment on term loan Payment on term loan Revenue from contract with customer milestone method factors. Revenue From Contract With Customer Milestone Method Factors Milestone payment agreement terms Number Of Pre Funded Warrants Exercised For Common Stock Number Of Pre Funded Warrants Exercised For Common Stock Operating Expenses [Abstract] Operating expenses: Property, Plant and Equipment [Abstract] Entity Voluntary Filers Entity Voluntary Filers Proceeds from License Fees Received License fees Debt Securities, Available-for-Sale [Table Text Block] Summary of Available-for-Sale Securities Share based compensation arrangement by share based payment award offering period discount rate. Share Based Compensation Arrangement By Share Based Payment Award Offering Period Discount Rate Offering period discount rate Prepaid state and local taxes Prepaid State and Local Taxes Prepaid State and Local Taxes Commitments and Contingencies Disclosure [Abstract] Other Assets, Noncurrent Other assets Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Share-based compensation, stock options granted Options granted Other Accrued Liabilities, Current Other Stock issued during period shares at the market offering net. Stock Issued During Period Shares At The Market Offering Net Proceeds from "at-the-market" offering, net, Shares Line of Credit Facility, Increase (Decrease), Net Aggregate maximum borrowing capacity increase Line of Credit Facility, Increase (Decrease), Net, Total Depreciation Depreciation expense Depreciation, Total Interest Paid, Excluding Capitalized Interest, Operating Activities Interest paid Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Earnings Per Share Basic [Line Items] Proceeds from Sale of Machinery and Equipment Proceeds from sales of equipment Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Unrealized Gains Equity, Attributable to Parent [Abstract] Stockholders' equity: Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Entity [Domain] Entity Line of Credit Facility, Maximum Borrowing Capacity Aggregate maximum borrowings Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule of Common Stock Reserved for Future Issuance Lessor, Operating Lease, Term of Contract Operating lease term of contract Derivative Liability, Measurement Input Derivative Liability, Measurement Input Schedule of Cash Flow, Supplemental Disclosures [Table Text Block] Supplemental Disclosures of Cash Flow Information Earnings Per Share [Abstract] Net (loss) income Per Share: Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Summary of Future Minimum Lease Payments under Operating Leases Michael Metzger [Member] Michael Metzger [Member] Michael Metzger [Member] Accounting Policies [Abstract] Cowen and Company LLC. Cowen And Company L L C [Member] Cowen and Company LLC [Member] Lessee Disclosure [Abstract] Lessee, Lease, Description [Table] Lessee Lease Description [Table] Adjustments to additional paid in capital deemed dividend from repricing warrants. Adjustments To Additional Paid In Capital Deemed Dividend From Repricing Warrants Deemed dividend from repricing Series 1 and 2 warrants Prepaid Subscriptions Prepaid Subscriptions PrepaidSubscriptions Scenario [Axis] Scenario Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentrations of Credit Risk Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Earnings Per Share, Basic Earnings Per Share, Basic, Total Basic (loss) earnings per share attributable to common stockholders Collaboration and license agreement cash consideration. Collaboration And License Agreement Cash Consideration Total cash consideration Commitments and contingencies (Note 16) Commitments and Contingencies Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Year Performance obligation period Income Statement [Abstract] Lease commencement date. Lease Commencement Date Lease Commencement Date Property, Plant and Equipment Disclosure [Text Block] Property and Equipment, net Commercial Paper, Not Included with Cash and Cash Equivalents [Member] Commercial Paper [Member] Two thousand and nineteen performance awards. Two Thousand And Nineteen Performance Awards [Member] 2019 Performance Awards Payment of facility charges. Payment Of Facility Charges Facility charge paid Performance Shares [Member] Performance Based Shares [Member] Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Interest or penalties recorded during the period Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense, Total Tangible Asset Impairment Charges Impairment charge Tangible Asset Impairment Charges, Total Measurement Input Type [Axis] Measurement Input Type Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Share-based compensation, stock options vested Options vested, exercisable or expected to vest, Ending balance Statistical Measurement [Domain] Statistical Measurement Net cash (used in) provided by operating activities Net Cash Provided by (Used in) Operating Activities Income Taxes [Table] Income Taxes [Table] Income Taxes [Table] Document Period End Date Document Period End Date Statistical Measurement [Axis] Statistical Measurement Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Accrued milestone costs Accrued milestone costs Accrued milestone costs Operating Lease, Payments Lease payments Follow-on public offering one. Follow On Public Offering One [Member] Follow-on Public Offering One [Member] Earnings Per Share, Diluted Earnings Per Share, Diluted, Total Diluted (loss) earnings per share attributable to common stockholders Gross proceeds from offering. Gross Proceeds From Offering Gross proceeds from offering Deferred Tax Assets, Operating Loss Carryforwards, Domestic Federal net operating losses Deferred Tax Assets, Operating Loss Carryforwards Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards, Total Unrecognized Tax Benefits Unrecognized tax benefit--end of year Unrecognized tax benefit--beginning of year Deferred Tax Assets, Operating Loss Carryforwards, State and Local State net operating losses Series one warrants. Series One Warrants [Member] Series 1 Warrants [Member] Internal Revenue Service (IRS) [Member] Internal Revenue Service [Member] Debt Instrument, Name [Domain] Debt Instrument, Name Derivative Liability Derivative Liability Derivative Liability, Total Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Options exercisable, Ending balance Related Party Transaction [Domain] Related Party Transaction Milestone Expenses Paid Milestone Expenses Paid Milestone expenses paid Additional Paid in Capital, Common Stock Additional paid-in capital Schedule of Maturities of Long-Term Debt [Table Text Block] Summary of Maturities of Principal Obligations Under Long-term Debt Deferred Tax Assets, Net, Total Deferred Tax Assets, Net Deferred tax asset US Treasury Securities [Member] U.S. Treasury [Member] Components of Deferred Tax Assets and Liabilities [Abstract] Deferred tax assets (liabilities): Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Proceeds from exercise of stock options, Shares Stock options exercised, shares Options exercised Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Other Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Percentage of end of term charge to future draws. Percentage Of End Of Term Charge To Future Draws Percentage of end of term charge to future draws Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Schedule Of Earnings Per Share Basic By Common Class [Table] Measurement Input, Option Volatility [Member] Volatility [Member] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Interactive Data Current Entity Interactive Data Current Private Placement [Member] Private Placement [Member] Number of series of warrants. Number Of Series Of Warrants Number of series of warrants Unrecognized Tax Benefits that Would Impact Effective Tax Rate Unrecognized income tax benefits that would affect effective tax rate Measurement Input, Discount Rate [Member] Discount Rate [Member] Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Accounts Payable, Total Revenue, Product and Service [Extensible Enumeration] Type of revenue [extensible list] Credit Facility [Domain] Credit Facility Equity [Abstract] Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less: imputed interest Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Number of Shares, Granted Restricted stock units granted Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Options exercised, Weighted Average Exercise Price Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Cash and Cash Equivalents, Policy [Policy Text Block] Cash Equivalents Equity Components [Axis] Equity Components Summary of Income Tax Contingencies [Table Text Block] Summary of Reconciliation of Company's Unrecognized Tax Benefits Offering cost. Offering Cost Offering costs Derivative liability. Derivative Liability [Member] Derivative Liability [Member] Two Thousand Twenty Three Performance Awards [Member] Two Thousand Twenty Three Performance Awards [Member] Office Equipment [Member] Office Equipment Under Capital Lease [Member] Term loan. Term Loan [Member] Term Loan [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Vested Local Phone Number Local Phone Number Property, Plant and Equipment [Line Items] Property Plant And Equipment [Line Items] Sale of Stock [Axis] Sale of Stock Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Options exercisable, Weighted Average Exercise Price, Ending balance Stock issued during period value direct offering common stock warrant. Stock Issued During Period Value Direct Offering Common Stock Warrant Direct offering, common stock warrants Par Value adjustment Par Value Adjustments Par Value Adjustments Restricted Cash, Current Restricted cash Statement of Cash Flows [Abstract] Warrant, Down Round Feature, Increase (Decrease) in Equity, Amount Deemed dividend due to warrant reset Equity plans [Member] Equity plans [Member] Equity plans [Member] Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block] Fair Value Measurements Income Tax Authority [Domain] Income Tax Authority Organization, Consolidation and Presentation of Financial Statements [Abstract] Property, Plant and Equipment, Policy [Policy Text Block] Property and Equipment Document Annual Report Document Annual Report Common Stock, Par or Stated Value Per Share Common stock, par value License agreements expiration period. License Agreements Expiration Period License expiration year Increase decrease in research and development expense. Increase Decrease In Research And Development Expense Cost-sharing collaborations recorded as a reduction to research and development expense Debt Instrument, Interest Rate, Stated Percentage Interest rate Begin to expire in 2026. Begin To Expire In Two Thousand And Twenty Six [Member] Begin to Expire in 2026 [Member] Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Weighted average period to recognize compensation expense Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Options vested, exercisable or expected to vest, Weighted Average Remaining Contractual Term, Ending balance Effective Income Tax Rate Reconciliation, Percent [Abstract] Collaboration payable, net Collaboration Payable, Current Collaboration Payable, Current Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Maximum [Member] Maximum [Member] Collaboration receivable, net Collaboration receivable Collaboration receivable Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights Vesting period, description Related Party Transaction [Axis] Related Party Transaction Deferred tax asset, capitalized research and development costs. Deferred Tax Assets Capitalized Research And Development Costs Capitalized research and development costs Scenario two. Scenario Two [Member] Available through November 30, 2022 [Member] Fair Value, Inputs, Level 3 [Member] Significant Unobservable Inputs Level 3 [Member] APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total Fair Value, Recurring and Nonrecurring [Table] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Deferred Tax Assets, Tax Deferred Expense, Total Deferred Tax Assets, Tax Deferred Expense Deferred tax assets, Expenses required to be capitalized Research and Development Arrangement, Contract to Perform for Others [Line Items] Research And Development Arrangement Contract To Perform For Others [Line Items] Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH Debt instrument, tranche three. Debt Instrument Tranche Three [Member] Tranche 3 [Member] Clinical Trial Cost [Policy Text Block] Clinical Trial Cost [Policy Text Block] Clinical Costs Percentage of facility charge of future draws. Percentage Of Facility Charge Of Future Draws Percentage of facility charge of future draws Payables and Accruals [Abstract] Biotechnology Value Fund, L.P. Biotechnology Value Fund L P [Member] Biotechnology Value Fund, L.P. [Member] Follow-on public offering two. Follow On Public Offering Two [Member] Follow-on Public Offering Two [Member] Milestone payment due. Milestone Payment Due Milestone payment payable Noncash Investing and Financing Items [Abstract] Supplemental Disclosures of Non-Cash Investing and Financing Activities: Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Dilutive potential common shares Follow on public offerings. Follow On Public Offerings [Member] Follow-on Public Offerings [Member] First amendment to loan and security agreement. First Amendment To Loan And Security Agreement [Member] First Amendment to Loan Agreement [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Share-based compensation, stock options cancelled Document Financial Statement Error Correction [Flag] License agreement. License Agreement [Member] License Agreement [Member] Potential Dilutive Securities Excluded from Computation of Diluted Net Loss per Common Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Fair Value, by Balance Sheet Grouping [Table Text Block] Significant Unobservable Inputs in the Fair Value Measurement City Area Code City Area Code Net Cash Provided by (Used in) Operating Activities [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Number of common stock converted to warrants. Number Of Common Stock Converted To Warrants Number of common stock converted to warrants Equity Method Investments [Member] Equity Investment [Member] Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance Selling, General and Administrative [Member] Selling, General and Administrative Expenses [Member] Warrants exercised period. Warrants Exercised Period Warrants exercised period Weighted Average Number of Shares Outstanding, Basic Weighted-average common shares outstanding Weighted Average Number of Shares Outstanding, Basic, Total Basic (loss) earnings per share attributable to common stockholders Collaboration expense due to counterparty. Collaboration Expense Due To Counterparty Collaboration expense due to counterparty Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value Weighted average grant date fair value per share Employee withholdings ESPP Employee withholdings ESPP Employee withholdings ESPP Development costs associated with clinical trials. Development Costs Associated With Clinical Trials Development costs associated with clinical trials Employee Stock [Member] ESPP to Purchase Common Stock Net Cash Provided by (Used in) Financing Activities [Abstract] CASH FLOWS FROM FINANCING ACTIVITIES: Research and Development Expense, Policy [Policy Text Block] Research and Development Stock issued during period value direct offering. Stock Issued During Period Value Direct Offering Proceeds from direct offering, net, value Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Summary of Restricted Stock Units Activity Statement [Table] Statement [Table] Share-Based Payment Arrangement, Option, Activity [Table Text Block] Summary of Employee and Non-Employee Option Activity Increase (Decrease) in Contract with Customer, Liability Deferred revenue Document Fiscal Period Focus Document Fiscal Period Focus Lessee, Operating Lease, Liability, to be Paid Total lease payments Liabilities, Noncurrent Total long-term liabilities 2025 Lessee, Operating Lease, Liability, to be Paid, Year Two Accrued Professional Fees, Current Accrued professional fees Statement [Line Items] Statement [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Anti-dilutive securities excluded from computation of diluted net loss per common share Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Beginning Balance 1/1/2022 Ending Balance 12/31/2022 Asset Class [Domain] Asset Class Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Components of Deferred Tax Derivatives, Policy [Policy Text Block] Derivative Financial Instruments Common Stock [Member] Common Stock [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Employee stock purchase plan. Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan [Member] Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value, Total Contractual obligations term. Contractual Obligations Term Period of contractual obligation Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Share Based Compensation Expense Related to Issuance of Stock Option Awards to Employees and Non Employees Related to Employee Stock Purchase Plan Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Options exercisable, Aggregate Intrinsic Value Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Change In Fair Value Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Change In Fair Value Change in fair value Change in fair value (Accretion) amortization of investments Accretion (Amortization) of Discounts and Premiums, Investments Deferred tax assets operating loss carryforwards expiration period. Deferred Tax Assets Operating Loss Carryforwards Expiration Period Operating loss carryforward expiration period Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Line of credit facility minimum cash covenant. Line Of Credit Facility Minimum Cash Covenant Minimum cash covenant Antidilutive Securities, Name [Domain] Antidilutive Securities, Name Warrant, cashless exercise, amount Warrant Cashless Exercise Amount Warrant Cashless Exercise Amount Common stock disclosure. Common Stock Disclosure [Text Block] Common Stock Guarantor Obligations, Nature [Domain] Guarantor Obligations, Nature Deposits Assets, Current Short-term deposits Registration Payment Arrangement, Arrangement [Domain] Registration Payment Arrangement, Arrangement Guarantor Obligations, Nature [Axis] Guarantor Obligations, Nature Exercise of warrants lower limit after exercise as percentage of common stock. Exercise Of Warrants Lower Limit After Exercise As Percentage Of Common Stock Minimum percentage of common stock can be held upon exercise of warrant Cover [Abstract] Selling, general and administrative Selling, General and Administrative Expense Selling, General and Administrative Expense, Total Document Fiscal Year Focus Document Fiscal Year Focus Sale of Stock [Domain] Sale of Stock Share-Based Payment Arrangement [Policy Text Block] Stock-Based Compensation Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Granted Potential milestone payments upon achievement of milestone. Potential Milestone Payments Upon Achievement Of Milestone Potential milestone payments to be made Number of warrants exercised in cashless exercise. Number Of Warrants Exercised In Cashless Exercise Warrants exercised Security Exchange Name Security Exchange Name Long-Term Investments, Total Long-Term Investments Long-term investments Domestic Tax Authority [Member] Federal [Member] New Accounting Pronouncements, Policy [Policy Text Block] Recently Issued and Adopted Accounting Pronouncements Preferred Stock, Shares Authorized Preferred stock, shares authorized Property, Plant and Equipment, Gross Property and equipment, gross Property, Plant and Equipment, Gross, Total Property, Plant and Equipment, Gross, Beginning Balance Property, Plant and Equipment, Gross, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares Share-based compensation, stock options vested Class of warrant or right term. Class Of Warrant Or Right Term Warrant term Current State Income Expense Current State and Local Tax Expense (Benefit) Summary of significant accounting policies. Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Legal Entity [Axis] Legal Entity Additional term loan. Additional Term Loan [Member] Additional Term Loan [Member] Weighted Average Number of Shares Outstanding, Diluted [Abstract] Weighted-average common shares used in calculating: Denominator: Warrants and Rights Outstanding, Term Weighted average expected term Development and regulaotry milestones Expenses Development and regulaotry milestones Expenses Development and regulaotry milestones expenses Stock Issued During Period, Value, Stock Options Exercised Proceeds from exercise of stock options Entity Emerging Growth Company Entity Emerging Growth Company Series one and series two warrants. Series One And Series Two Warrants [Member] Series 1 and Series 2 Warrants [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Options Exercised, Aggregate Intrinsic Value Intrinsic value of options exercised Amendment Flag Amendment Flag Percentage of income tax contingency realized. Percentage Of Income Tax Contingency Realized Percentage of income tax contingency realized IPO [Member] Initial Public Offering [Member] Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Unrealized Losses Accounting Standards Update [Domain] Accounting Standards Update Percentage of prepayment premium of principal amount outstanding in second year. Percentage Of Prepayment Premium Of Principal Amount Outstanding In Second Year Percentage of prepayment premium of principal amount outstanding in second year Other Current Assets [Text Block] Prepaid Expenses and Other Current Assets Two thousand fifteen omnibus incentive plan. Two Thousand Fifteen Omnibus Incentive Plan [Member] 2015 Plan [Member] Derivative, Gain (Loss) on Derivative, Net Derivative, Gain (Loss) on Derivative, Net, Total Changes in fair value of derivative liability UCB Biopharma. U C B Biopharma [Member] UCB Biopharma [Member] Variable Rate [Domain] Variable Rate Stock issued during period shares exercise of warrants. Stock Issued During Period Shares Exercise Of Warrants Exercise of Series 1 and Series 2 warrants, Shares Deferred tax asset, capitalized start-up and other costs. Deferred Tax Assets Capitalized Start Up And Other Costs Capitalized start-up and other costs Tax Period [Domain] Tax Period Securities Act File Number Entity File Number Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] Upfront license fees paid. Upfront License Fees Paid Up-front license fee paid Vitae Pharmaceuticals, Inc. Vitae Pharmaceuticals Inc [Member] Vitae Pharmaceuticals Inc [Member] Commitment and contingencies. Commitment And Contingencies [Line Items] Commitment And Contingencies [Line Items] Deferred Tax Assets, Gross Deferred tax assets before valuation allowance Incyte collaboration agreement and share purchase agreement. Incyte Collaboration Agreement And Share Purchase Agreement [Member] Incyte Collaboration Agreement and Share Purchase Agreement [Member] Number of pre-funded warrants exchanged for common stock. Number Of Pre Funded Warrants Exchanged For Common Stock Pre-funded warrants exchange Unrealized (gain) loss on investments Unrealized gain (loss) on marketable securities, net of tax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Expiration of the ESPP Expiration of the ESPP Fair value measurement with unobservable inputs reconciliations recurring basis liability value additions. Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value Additions Additions Share-Based Payment Arrangement [Abstract] Indefinite carryforward period. Indefinite Carryforward Period [Member] Indefinite Carryforward Period [Member] Bayer Pharma AG . Bayer Pharma Ag [Member] Bayer Pharma AG [Member] Non-cash operating lease expense. Noncash Operating Lease Expense Non-cash operating lease expense Warrants and Rights Outstanding, Measurement Input Warrants and rights outstanding, measurement input Direct placement offering. Direct Placement Offering [Member] Direct Placement Offering [Member] At the market stock offering. At The Market Stock Offering [Member] At-the-Market Offering [Member] Accounts Payable, Current Accounts payable Accounts Payable, Current, Total Debt Instrument [Axis] Debt Instrument Upfront payment allocated to equity purchase. Upfront Payment Allocated To Equity Purchase Up-front payment allocated to equity purchase Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Unvested, Ending balance Weighted Average Grant Date Fair Value, Unvested, Beginning balance Loans Payable, Current Current portion of term loan Loans Payable, Current, Total Deferred Tax Assets, Valuation Allowance Valuation allowances Operating Expenses Total operating expenses Accrued clinical costs current. Accrued Clinical Costs Current Accrued clinical study and trial costs Long-Term Debt, Maturity, Year One 2022 Auditor Location Auditor Location Accrued expenses Accrued Liabilities and Other Liabilities Accrued expenses and other current liabilities Total accrued expenses and other current liabilities Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Expected term (in years) Collaborative Arrangement [Member] Cost-Sharing Collaborations [Member] Entity Address, Address Line Two Entity Address, Address Line Two Preferred stock, $0.001 par value, 10,000,000 shares authorized; 0 shares outstanding at December 31, 2023 and December 31, 2022 Preferred Stock, Value, Issued Entity Small Business Entity Small Business Entity Shell Company Entity Shell Company Number of Operating Segments Number of operating segments Title of Individual [Axis] Title of Individual Two thousand and seven stock incentive plan. Two Thousand And Seven Stock Incentive Plan [Member] 2007 Plan [Member] Class of Warrant or Right, Exercise Price of Warrants or Rights Warrant exercise price per share Warrant exercise price per share Stock issued during period value common stock warrant with direct offering. Stock Issued During Period Value Common Stock Warrant With Direct Offering Issuance of common stock warrant with direct offering, value Liabilities, Noncurrent [Abstract] Long-term liabilities: (Loss) Earnings per Share Earnings Per Share [Text Block] Payment for end-of term fees Payment for end-of term fees Revenues [Abstract] Revenues: Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Options canceled, forfeited or expired Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Total Briggs W. Morrison [Member] Briggs W. Morrison [Member] Briggs W. Morrison [Member] Allergan license agreement. Allergan License Agreement [Member] Allergan License Agreement [Member] Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Income taxes. Income Taxes [Line Items] Income Taxes [Line Items] Entity Address, Address Line One Entity Address, Address Line One Cash and Cash Equivalents, Fair Value Disclosure Cash equivalents Contractual Obligation Aggregate payment obligation Contractual Obligation, Total market reserve Market Reserve [MEMBER] Market Reserve [MEMBER] Antidilutive Securities [Axis] Antidilutive Securities Increase decrease in collaboration receivable. Increase Decrease In Collaboration Receivable Collaboration receivable, net Accrued contractual obligation. Accrued Contractual Obligation Accrued contractual obligation Restricted Cash Restricted cash Restricted cash included in current and noncurrent assets Restricted Cash, Total Subsequent Event Type [Domain] Subsequent Event Type Prepaid rent Prepaid Rent Loan and security agreement. Loan And Security Agreement [Member] Loan Agreement [Member] Income Statement Location [Axis] Income Statement Location Long-Term Debt, Maturity, Year Three 2024 Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities Accruals Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected dividend yield Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net income (loss) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total Deferred Tax Assets, Deferred Income Deferred revenue Number of pre funded warrants cashless exchanged for common stock. Number Of Pre Funded Warrants Cashless Exchanged For Common Stock Pre-funded warrants cashless exchange Prepaid Insurance Prepaid insurance Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender Fair Value, Inputs, Level 2 [Member] Significant Other Observable Inputs Level 2 [Member] Upfront payment allocated to license fee. Upfront Payment Allocated To License Fee Up-front payment allocated to license fee Collaborative Arrangement and Arrangement Other than Collaborative [Table] Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table] expiration of the ESPP shares expiration of the ESPP shares Long-Term Debt, Gross Borrowings to date Total principal outstanding Incyte share purchase agreement. Incyte Share Purchase Agreement [Member] Incyte Share Purchase Agreement [Member] Title of 12(b) Security Title of 12(b) Security Percentage of prepayment premium of principal amount outstanding in first year. Percentage Of Prepayment Premium Of Principal Amount Outstanding In First Year Percentage of prepayment premium of principal amount outstanding in first year 2023 Inducement Plan [Member] Two Thousand Twenty Three Inducement Incentive Plan [Member] Two Thousand Twenty Three Inducement Incentive Plan [Member] Pre funded warrants. Pre Funded Warrants [Member] Pre-Funded Warrants [Member] Fair Value Measurements [Table] Fair Value Measurements [Table] Fair Value Measurements [Table] Stock issued during period value at the market offering expenses. Stock Issued During Period Value At The Market Offering Expenses At-the-market, offering expenses ATM Offering, offering cost Prime Rate [Member] Wall Street Journal Prime Rate [Member] Derivative Liability [Abstract] Derivative Liability: Number of employees retirement. Number Of Employees Retirement Number of employees retirement Lessee operating lease liability payments due after year three. Lessee Operating Lease Liability Payments Due After Year Three Thereafter Pre-funded warrant cashless exercise, shares Pre-funded warrant exercise, shares Pre-funded warrant exercise, shares Scenario one. Scenario One [Member] Available through April 30, 2022 [Member] Aggregate potential milestone payable. Aggregate Potential Milestone Payable Aggregate potential milestone payable Kyowa Kirin Co., Ltd. Kyowa Kirin Co Ltd [Member] Kyowa Kirin Co., Ltd. [Member] Income Tax Authority, Name [Axis] Income Tax Authority, Name Accounting Standards Update [Axis] Accounting Standards Update Global and united states. Global And United States [Member] Global and U.S. [Member] Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent Non-deductible expenses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent, Total Indemnification obligations claims reserves. Indemnification Obligations Claims Reserves Indemnification obligations claims, reserves established Net Cash Provided by (Used in) Investing Activities [Abstract] CASH FLOWS FROM INVESTING ACTIVITIES: Reported Value Measurement [Member] Carrying Value [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Common stock exercised non option State and Local Jurisdiction [Member] State [Member] Segment Reporting, Policy [Policy Text Block] Segment Reporting Portion at Fair Value Measurement [Member] Fair Value Disclosure Item Amounts [Default] Portion at Fair Value Measurement [Member] [Default] Warrants to purchase common stock. Warrants To Purchase Common Stock [Member] Warrants to Purchase Common Stock [Member] Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Restricted Cash Purchase Obligation Purchase agreement obligation Purchase Obligation, Total Contract with Customer, Liability Deferred revenue Contract with Customer, Liability, Total Lessee, Operating Lease, Existence of Option to Terminate [true false] Lease option to termination Defined Contribution Plan, Employer Discretionary Contribution Amount Contributions by the company Interest Expense, Debt Interest expense related to the loan agreement Interest Expense, Debt, Total Increase decrease in contractual obligation. Increase Decrease In Contractual Obligation Increase in contractual obligation Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Options exercisable, Weighted Average Remaining Contractual Term, Ending balance Non refundable cash payments. Non Refundable Cash Payments [Member] Non-Refundable Cash Payments [Member] Common Stock, Shares, Outstanding Common stock, shares outstanding Common Stock, Shares, Outstanding, Beginning Balance Common Stock, Shares, Outstanding, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate Share-Based Payment Arrangement [Text Block] Stock-Based Compensation Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Forfeited At the market equity offering sales agreement. At The Market Equity Offering Sales Agreement [Member] At The Market Equity Offering Sales Agreement [Member] Supplemental Cash Flow Elements [Abstract] Collaboration and license agreement consideration transaction price. Collaboration And License Agreement Consideration Transaction Price Total transaction price Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Unamortized Debt Issuance Expense Unamortized debt issuance costs Income Statement Location [Domain] Income Statement Location Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Options granted, Weighted Average Exercise Price Document Type Document Type Loans Payable, Noncurrent Term loan, less current portion Loans Payable, Noncurrent, Total Other Prepaid Expense, Current Other Debt instrument interest only period extendable upon partial or full draw of Tranche 2. Debt Instrument Interest Only Period Extendable Upon Partial Or Full Draw Of Tranche Two Interest-only period, extendable upon partial or full draw of Tranche 2 Line of Credit Facility, Interest Rate Description Interest rate description Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Potential milestone payments receivable. Potential Milestone Payments Receivable Milestone payment receivable upon achievement of development and commercial milestone Collaboration and license agreement allocated consideration received to derivative liability. Collaboration And License Agreement Allocated Consideration Received To Derivative Liability Allocated consideration received to derivative liability Counterparty Name [Domain] Counterparty Name Net Income (Loss) Available to Common Stockholders, Basic Net (loss) income attributable to common stockholders Net (loss) income attributable to common stockholders Number of Shares, Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Number of Shares, Forfeited Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Shares authorized for issuance Entity Filer Category Entity Filer Category Deferred Tax Assets, Tax Credit Carryforwards, Research Deferred tax assets research credits Fair value measurements. Fair Value Measurements [Line Items] Fair Value Measurements [Line Items] Eastern Cooperative Oncology Group. Eastern Cooperative Oncology Group [Member] Eastern Cooperative Oncology Group [Member] Income Tax Authority, Name [Domain] Income Tax Authority, Name Variable Rate [Axis] Variable Rate Short-Term Investments Short-term investments Short-Term Investments, Total Stock issued during period shares pre funded common stock warrants from direct offering. Stock Issued During Period Shares Pre Funded Common Stock Warrants From Direct Offering Proceeds from pre-funded common stock warrant from direct offering, net, Shares Asset Class [Axis] Asset Class Stock issued during period value pre-funded common stock warrant offering expenses. Stock Issued During Period Value Pre Funded Common Stock Warrant Offering Expenses Pre-funded common stock warrants offering expenses Nonoperating Income (Expense) Total other income (expense) Liabilities Total liabilities Property, Plant and Equipment [Table] Schedule Of Property Plant And Equipment [Table] Stock issued during period value pre funded common stock warrant. Stock Issued During Period Value Pre Funded Common Stock Warrant Pre-funded common stock warrants MASSACHUSETTS Waltham, Massachusetts [Member] Purchases of short and long-term investments Payments to Acquire Short-Term Investments Equity, Attributable to Parent Ending balance Beginning balance Total stockholders' equity Collaboration and license agreement. Collaboration And License Agreement [Member] Incyte Agreement [Member] Incyte Share Purchase Agreement [Member] Documents Incorporated by Reference [Text Block] Documents Incorporated by Reference Net (loss) income Net (loss) income Nonoperating Income (Expense) [Abstract] Other income (expense): Interest Expense Interest expense Interest Expense, Total Business Description and Basis of Presentation [Text Block] Basis of Presentation Schedule of Research and Development Arrangement, Contract to Perform for Others [Table] Schedule Of Research And Development Arrangement Contract To Perform For Others [Table] Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent State taxes, net of federal benefit Commercialization milestones and tiered royalties. Commercialization Milestones And Tiered Royalties Commercialization milestones and tiered royalties Name of Property [Axis] Corporate Debt Securities [Member] Corporate Bonds [Member] Statement of Financial Position [Abstract] Collaborative research and license agreements. Collaborative Research And License Agreements [Text Block] Collaborative Research and License Agreements Area of Real Estate Property Area of leased property Derivative Liability, Statement of Financial Position [Extensible Enumeration] Weighted Average Number of Shares Outstanding, Diluted Shares used in calculating diluted earnings (loss) per share Diluted (loss) earnings per share attributable to common stockholders Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Schedule of Reconciliation of Provision for Income Taxes Computed at Statutory Federal Income Tax Rate to Provision for Income Taxes Credit Facility [Axis] Credit Facility Shares Issued, Price Per Share Purchase price per share Effective Income Tax Rate Reconciliation, Percent Effective income tax rate Available For Sale Securities Fair Value Disclosure [Abstract] Available For Sale Securities Fair Value Disclosure [Abstract] Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Schedule of Accrued Expenses and Other Current Liabilities Debt Securities, Available-for-Sale, Amortized Cost Amortized Cost Operating Lease, Weighted Average Remaining Lease Term Remaining lease term Valuation technique Black Scholes Model. Valuation Technique Black Scholes Model [Member] Black Scholes Model [Member] Deferred tax assets research credits expiration period. Deferred Tax Assets Research Credits Expiration Period Deferred tax assets research credits expiration period Use of Estimates, Policy [Policy Text Block] Estimates Income Tax Disclosure [Text Block] Income Taxes Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Options outstanding, Weighted Average Exercise Price, Ending balance Options outstanding, Weighted Average Exercise Price, Beginning balance Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Computation of Basic and Diluted Earnings (Loss) per Share Valuation Approach and Technique [Axis] Valuation Approach and Technique Leasehold Improvements [Member] Leasehold Improvements [Member] Income Tax Authority [Axis] Income Tax Authority Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Series warrants. Series Warrants [Member] Series Warrants [Member] Fair Value Disclosures [Abstract] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV Non-cash interest income (expense) Paid in kind interest and interest reversal. Paid In Kind Interest And Interest Reversal Payments to Acquire Property, Plant, and Equipment Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment, Total Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Restricted stock units vested Number of Shares, Vested Stock Issued During Period, Shares, New Issues Common stock, new shares issued Proceeds from Incyte Share Purchase Agreement shares Employee-related Liabilities, Current Accrued compensation and related costs Employee-related Liabilities, Current, Total Operating Lease, Expense Operating lease expense Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations CASH, CASH EQUIVALENTS AND RESTRICTED CASH—end of year CASH, CASH EQUIVALENTS AND RESTRICTED CASH—beginning of year Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total Income Tax Disclosure [Abstract] Period of termination after first commercial sale of first licensed product. Period Of Termination After First Commercial Sale Of First Licensed Product Period of termination after first commercial sale of first licensed product